Of all the different types of cancers known to man, bone cancer is one of the rarest kinds and is generally found to effect young males between the ages of 10 to 25 years. However, the metastatic form of bone cancer is more common in adults and it is generally a cancer that originates in some other body part and then spreads to the bones. Life expectancy in metastatic bone cancer depends on the treatment of the original cancer which is generally found in the breast, prostate, lung, kidney and thyroid.
For greater life expectancy in metastatic bone cancer it is vital to achieve two main goals. The first goal is of managing the neoplasm and the second goal is to manage the symptoms produced by local abrasion. Other factors that affect the diagnosis and treatment of this disease include the age of the patient, the size of the original tumor, the extent to which the lymphatic & blood vessels are affected, the duration for which the symptoms have been present as well as the exact location of the metastatic tumor on the arm, trunk or lung.
Metastatic bone cancer is generally treated in two different ways. The first way is through systematic therapy in which the cancer cells spread throughout the body are taken care of. This treatment is administered through hormone therapy, immunotherapy and chemotherapy. The other way of treating bone cancer is through local therapy in which the cancer cells located in a specific body part are eliminated. This treatment is administered through surgery and radiation therapy.
In many cases, it is found that some small tumors might still be left undetected in the body causing the revival of cancer. For increasing the life expectancy of metastatic bone cancer patients in such cases, chemotherapy is the most widely used treatment aimed at removing the remaining tumors. The associated pain that results from chemotherapy treatment is treated with safe and effective medicines, which enables the patients to carry on their everyday activities without much hindrance.
The tremendous developments made in the field of medical science have considerably increased the life expectancy of metastatic bone cancer patients. In this context the modern methods of chemotherapy have greatly helped in improving the probability of a patient recovering from the disease. Besides medication the overall recovery of the patient also depends on various other factors including the patient’s current and general health condition as well as his toleration for the treatment.
The life expectancy of metastatic bone cancer patients can increase tremendously if the disease is detected at an early stage and the tumor is quite small and is just confined to a single body part. In such cases, the overall recovery rate for patients is as high as 90% with the chances of survival of up to five years. However, as the cancer begins to spread and the tumor size increases, the recovery rate starts decreasing and the chances of patients surviving even for five years reduces to only 60%.